Publications by authors named "Gesese Bogale Awgichew"
Background: Long-term use of antiretroviral therapy, especially dolutegravir and boosted-atazanavir, raises concerns about cardiovascular disease. Thus, this study aimed to assess lipid profiles, blood glucose, and high-sensitivity C-reactive protein levels among people living with HIV on dolutegravir and ritonavir-boosted atazanavir-based therapy.
Methods: An institutional-based comparative cross-sectional study was conducted from November 4, 2021, to January 4, 2022.